BIRC5 and breast carcinoma: Specifically, increased level of BIRC5 was observed in medullary breast carcinoma, invasive ductal breast carcinoma, invasive breast carcinoma, invasive ductal and invasive lobular breast carcinoma, breast carcinoma, invasive lobular breast carcinoma, and intraductal cribriform breast adenocarcinoma with respect to normal tissues (Figure 2A–I).